Tandem Molecular Self-Assembly Selectively Inhibits Lung Cancer Cells by Inducing Endoplasmic Reticulum Stress

• Published in: Research (Washington) 2019-01, Vol.2019, p.4803624-4803624
• Main Authors: Zheng, Debin, Chen, Yumiao, Ai, Sifan, Zhang, Renshu, Gao, Zhengfeng, Liang, Chunhui, Cao, Li, Chen, Yaoxia, Hong, Zhangyong, Shi, Yang, Wang, Ling, Li, Xingyi, Yang, Zhimou
• Format: Article
• Language: English
• ISSN: 2639-5274; 2639-5274
• DOI: 10.34133/2019/4803624

The selective formation of nanomaterials in cancer cells and tumors holds great promise for cancer diagnostics and therapy. Until now, most strategies rely on a single trigger to control the formation of nanomaterials . The combination of two or more triggers may provide for more sophisticated means of manipulation. In this study, we rationally designed a molecule ( ) capable of responding to two enzymes, alkaline phosphatase (ALP), and reductase. Since the A549 lung cancer cell line showed elevated levels of extracellular ALP and intracellular reductase, we demonstrated that responded in a stepwise fashion to those two enzymes and displayed a tandem molecular self-assembly behavior. The selective formation of nanofibers in the mitochondria of the lung cancer cells led to the disruption of the mitochondrial membrane, resulting in an increased level of reactive oxygen species (ROS) and the release of cytochrome C (Cyt C). ROS can react with proteins, resulting in endoplasmic reticulum (ER) stress and the unfolded protein response (UPR). This severe ER stress led to disruption of the ER, formation of vacuoles, and ultimately, apoptosis of the A549 cells. Therefore, could selectively inhibit lung cancer cells and A549 xenograft tumors . Our study provides a novel strategy for the selective formation of nanomaterials in lung cancer cells, which is powerful and promising for the diagnosis and treatment of lung cancer.